Already positive, the research from Goldman Sachs and its analyst Patrick Creuset still consider the stock as a Buy opportunity. The target price is unchanged and still at EUR 132. | April 25, 2023
In a research note published by Patrick Creuset, Goldman Sachs gives a Neutral rating to the stock. The target price has been revised upwards and is now set at GBX 550, compared with GBX 515. | April 25, 2023
In his latest research note, analyst Patrick Creuset confirms his recommendation. The broker Goldman Sachs is keeping its Neutral rating. The target price continues to be set at GBX 515. | April 19, 2023
In his latest research note, analyst Patrick Creuset confirms his recommendation. The broker Goldman Sachs is keeping its Neutral rating. The target price remains set at EUR 40. | November 21, 2022